Is KALV stock safe? | Glauxie AI

Q: Is KALV stock safe?

KalVista Pharmaceuticals, Inc. (KALV) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Benjamin L. Palleiko. KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's... Employees: 270.

Q: What are the risks of investing in KALV?

Identify key risks of investing in KALV — debt, competition, volatility, and sector headwinds.

Q: Is KALV a good long-term investment?

Evaluate KALV as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does KALV have?

Review KALV total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is KALV stock safe?

🦉

KalVista Pharmaceuticals, Inc. (KALV)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOBenjamin L. Palleiko

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema...

Key Executives

Name	Title
Benjamin L. Palleiko	Chief Executive Officer & Director
Bilal Arif	Chief Operating Officer
Brian Krex	General Counsel
Brian Piekos	Chief Financial Officer
Christopher L. Hamblett	Senior Vice President of Corporate Development
Christopher Yea	Chief Development Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

KALV Profile Financials

What are the risks of investing in KALV? Is KALV a good long-term investment? How much debt does KALV have?